Shimada, Hiroko

写真a

Affiliation

School of Medicine, Department of Physiology （Shinanomachi）

Position

Project Senior Assistant Professor (Non-tenured)/Project Assistant Professor (Non-tenured)/Project Lecturer (Non-tenured)
Page Top ▲

Career 【 Display / hide 】

  • 2013.07
    -
    2016.12

    National Eye Institute (NEI) / NIH

Page Top ▲
 

Research Keywords 【 Display / hide 】

  • Stem cell, Neural differentiation

Page Top ▲
 

Papers 【 Display / hide 】

  • Human PSCs determine the competency of cerebral organoid differentiation via FGF signaling and epigenetic mechanisms

    Ideno H., Imaizumi K., Shimada H., Sanosaka T., Nemoto A., Kohyama J., Okano H.

    iScience （iScience)  25 （ 10 ）  2022.10

    　View Summary

    Various culture methods have been developed for maintaining human pluripotent stem cells (PSCs). These PSC maintenance methods exhibit biased differentiation; for example, feeder-dependent PSCs efficiently yield cerebral organoids, but it is difficult to generate organoids from feeder-free PSCs. It remains unknown how PSC maintenance conditions affect differentiation. In this study, we identified fibroblast growth factor (FGF) signaling in feeder-free PSC maintenance as a key factor that determines the differentiation toward cerebral organoids. The inhibition of FGF signaling in feeder-free PSCs rescued organoid generation to the same level in feeder-dependent cultures. FGF inhibition induced DNA methylation at the WNT5A locus, and this epigenetic change suppressed the future activation of non-canonical Wnt signaling after differentiation, leading to reliable cerebral organoid generation. This study underscores the importance of PSC culture conditions for directed differentiation into cerebral organoids, and the epigenetic status regulated by FGF signaling is involved in the underlying mechanisms.

  • In vitro modeling and rescue of ciliopathy associated with IQCB1/NPHP5 mutations using patient-derived cells

    Kruczek K., Qu Z., Welby E., Shimada H., Hiriyanna S., English M.A., Zein W.M., Brooks B.P., Swaroop A.

    Stem Cell Reports （Stem Cell Reports)  17 （ 10 ） 2172 - 2186 2022.10

    ISSN  22136711

    　View Summary

    Mutations in the IQ calmodulin-binding motif containing B1 (IQCB1)/NPHP5 gene encoding the ciliary protein nephrocystin 5 cause early-onset blinding disease Leber congenital amaurosis (LCA), together with kidney dysfunction in Senior-Løken syndrome. For in vitro disease modeling, we obtained dermal fibroblasts from patients with NPHP5-LCA that were reprogrammed into induced pluripotent stem cells (iPSCs) and differentiated into retinal pigment epithelium (RPE) and retinal organoids. Patient fibroblasts and RPE demonstrated aberrantly elongated ciliary axonemes. Organoids revealed impaired development of outer segment structures, which are modified primary cilia, and mislocalization of visual pigments to photoreceptor cell soma. All patient-derived cells showed reduced levels of CEP290 protein, a critical cilia transition zone component interacting with NPHP5, providing a plausible mechanism for aberrant ciliary gating and cargo transport. Disease phenotype in NPHP5-LCA retinal organoids could be rescued by adeno-associated virus (AAV)-mediated IQCB1/NPHP5 gene augmentation therapy. Our studies thus establish a human disease model and a path for treatment of NPHP5-LCA.

  • A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer

    Shimada H., Sato Y., Sasaki T., Shimozawa A., Imaizumi K., Shindo T., Miyao S., Kiyama K., Kondo T., Shibata S., Ishii S., Kuromitsu J., Aoyagi H., Ito D., Okano H.

    Cell Reports Methods （Cell Reports Methods)  2 （ 9 ）  2022.09

    　View Summary

    It is known that the human cellular models of Alzheimer's disease (AD) and tauopathy can only recapitulate the very early stage of the disease. To overcome these limitations, we developed a technology to make forebrain organoids (FBOs) from feeder-free induced pluripotent stem cells (iPSC)s by regulating a FGF2 concentration and applied this method to generate FBOs from patients with familial AD (fAD FBOs). The obtained fAD FBOs recapitulated the amyloid-β pathology and increased tau phosphorylation but not tau aggregates. To fully induce the tau pathology, FBOs were injected with adeno-associated virus (AAV)-expressing P301L mutant tau. In these Tau-P301L FBOs, tau fibrils were observed in the neuronal cell body and neurites with immunoelectron microscopy, in addition to the sarkosyl-insoluble and thioflavin S-positive phospho-tau aggregates. Collectively, this model can be used as a platform for investigating pathogenetic mechanisms and evaluation of target molecules for drug discovery for tauopathy.

  • In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 Mutations

    Shimada, Hiroko, Lu, Quanlong, Insinna-Kettenhofen, Christine, Nagashima, Kunio, English, Milton A., Semler, Elizabeth M., Mahgerefteh, Jacklyn, Cideciyan, Artur V., Li, Tiansen, Brooks, Brian P., Gunay-Aygun, Meral, Jacobson, Samuel G., Cogliati, Tiziana, Westlake, Christopher J., Swaroop, Anand

    CELL REPORTS 20 （ 2 ） 384 - 396 2017.07

    Research paper (scientific journal),  ISSN  2211-1247

  • Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates

    Iwai, Hiroki, Shimada, Hiroko, Nishimura, Soraya, Kobayashi, Yoshiomi, Itakura, Go, Hori, Keiko, Hikishima, Keigo, Ebise, Hayao, Negishi, Naoko, Shibata, Shinsuke, Habu, Sonoko, Toyama, Yoshiaki, Nakamura, Masaya, Okano, Hideyuki

    STEM CELLS TRANSLATIONAL MEDICINE 4 （ 7 ） 708 - 719 2015.07

    Research paper (scientific journal),  ISSN  2157-6564

display all >>

Page Top ▲

Papers, etc., Registered in KOARA 【 Display / hide 】

Page Top ▲

Presentations 【 Display / hide 】

  • Development of induced pluripotent stem cells (iPSCs)-based therapies for blinding retinal neurodegenerative diseases.

    SHIMADA Hiroko

    2014 Focus on Fellows, NEI/NIH, 

    2014.10
    , 

    Poster presentation

  • Development of induced pluripotent stem cells (iPSCs)-based therapies for blinding retinal neurodegenerative diseases.

    SHIMADA Hiroko

    NIH-Japan-JSPS Symposium, 

    2014.10
    , 

    Poster presentation

  • Efficient derivation of neural stem cells from common marmoset ES　cells and iPS cells

    SHIMADA Hiroko

    ISSCR 10th Annual Meeting, 

    2012.06
    , 

    Poster presentation

  • Efficient derivation of neural stem cells from common marmoset ES　cells and iPS cells.

    SHIMADA Hiroko

    Frontiers in Biomedical Researches on Marmosets as a Primate Model Japan Society for Marmoset Research, 

    2012.02
    , 

    Poster presentation

  • Efficient derivation of neural stem cells from common marmoset ES cells and iPS cells

    SHIMADA Hiroko

    Neuroscience 2011, SfN's 41st annual meeting, 

    2011.11
    , 

    Poster presentation

display all >>

Page Top ▲

Awards 【 Display / hide 】

  • International Society for Stem Cell Research (ISSCR), Travel award

    2011.06

Page Top ▲
 

Courses Taught 【 Display / hide 】

  • PHYSIOLOGY 2

    2023

  • PHYSIOLOGY 2

    2022

  • PHYSIOLOGY 2

    2021

  • PHYSIOLOGY 2

    2020

Page Top ▲